APP (Phospho-S198) Antibody Blocking peptide

Amyloid beta A4 protein, ABPP, APPI, APP, Alzheimer disease amyloid protein, Cerebral vascular amyloid peptide, CVAP, PreA4, Protease nexin-II, PN-II, N-APP, Soluble APP-alpha, S-APP-alpha, Soluble APP-beta, S-APP-beta, C99, Beta-amyloid protein 42, Beta-APP42, Beta-amyloid protein 40, Beta-APP40, C83, P3 (42), P3 (40), C80, Gamma-secretase C-terminal fragment 59, Amyloid intracellular domain 59, AICD-59, AID (59), Gamma-CTF (59), Gamma-secretase C-terminal fragment 57, Amyloid intracellular domain 57, AICD-57, AID (57), Gamma-CTF (57), Gamma-secretase C-terminal fragment 50, Amyloid intracellular domain 50, AICD-50, AID (50), Gamma-CTF (50), C31, APP, A4, AD1

The synthetic peptide sequence was selected from the region of human Phospho-APP-S198. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.